Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · IEX Real-Time Price · USD
0.835
-0.012 (-1.39%)
At close: Jul 19, 2024, 4:00 PM
0.760
-0.075 (-9.00%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Achilles Therapeutics Market Cap
Achilles Therapeutics has a market cap or net worth of $34.32 million as of July 22, 2024. Its market cap has decreased by -11.78% in one year.
Market Cap
34.32M
Enterprise Value
-73.79M
1-Year Change
-11.78%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on March 31, 2021, Achilles Therapeutics's market cap has decreased from $731.19M to $34.32M, a decrease of -95.31%. That is a compound annual growth rate of -60.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 34.30M | -5.51% |
| Dec 29, 2023 | 36.30M | -1.36% |
| Dec 30, 2022 | 36.80M | -81.91% |
| Dec 31, 2021 | 203.40M | -72.18% |
| Mar 31, 2021 | 731.19M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IceCure Medical | 35.78M |
| Aadi Bioscience | 35.11M |
| IGC Pharma | 34.79M |
| Cyclo Therapeutics | 34.62M |
| iCAD, Inc. | 34.50M |
| Unicycive Therapeutics | 34.27M |
| Exagen | 34.05M |
| Nutex Health | 33.88M |